共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R019143-5mg | 5mg | 5~7个工作日 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... N-[4-[3-chloro-4-[(3-fluorop... |
98% |
|
|
罗恩 | R019143-10mg | 10mg | 5~7个工作日 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... N-[4-[3-chloro-4-[(3-fluorop... |
98% |
|
|
阿拉丁 | A129426-5mg | 5mg | 现货 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... AST-1306 TsOH |
≥98% |
|
|
阿拉丁 | A129426-10mg | 10mg | 现货 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... AST-1306 TsOH |
≥98% |
|
|
阿拉丁 | A129426-50mg | 50mg | 现货 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... AST-1306 TsOH |
≥98% |
|
|
阿拉丁 | A408612-1ml | 1ml | 现货 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... Allitinib (AST-1306) |
10mM in DMSO |
|
|
凯为 | JZ008UDO-10mg | 10mg | 期货,请咨询 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... AST-1306 |
99% |
|
|
凯为 | JZ008UDO-25mg | 25mg | 期货,请咨询 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... AST-1306 |
99% |
|
|
凯为 | JZ008UDO-1mg | 1mg | 期货,请咨询 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... AST-1306 |
99% |
|
|
凯为 | JZ008UDO-5mg | 5mg | 期货,请咨询 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... AST-1306 |
99% |
|
|
毕得 | BD763120-5mg | 5mg | 现货 |
N-(4-((3-氯-4-((3-氟苄基)氧基)苯基)氨... N-(4-((3-Chloro-4-((3-fluoro... |
99% |
|
|
毕得 | BD763120-10mg | 10mg | 现货 |
N-(4-((3-氯-4-((3-氟苄基)氧基)苯基)氨... N-(4-((3-Chloro-4-((3-fluoro... |
99% |
|
|
毕得 | BD763120-25mg | 25mg | 现货 |
N-(4-((3-氯-4-((3-氟苄基)氧基)苯基)氨... N-(4-((3-Chloro-4-((3-fluoro... |
99% |
|
|
毕得 | BD763120-50mg | 50mg | 现货 |
N-(4-((3-氯-4-((3-氟苄基)氧基)苯基)氨... N-(4-((3-Chloro-4-((3-fluoro... |
99% |
|
|
毕得 | BD763120-1mg | 1mg | 现货 |
N-(4-((3-氯-4-((3-氟苄基)氧基)苯基)氨... N-(4-((3-Chloro-4-((3-fluoro... |
99% |
|
|
百灵威 | JK2275899-2MG | 2MG | 1天 |
Allitinib tosylate Allitinib tosylate, 98%, a n... |
98% |
|
|
百灵威 | JK2275899-10MG | 10MG | 1天 |
Allitinib tosylate Allitinib tosylate, 98%, a n... |
98% |
|
|
源叶 | S40475-5mg | 5mg | 期货,请咨询 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... AST-1306 TsOH |
≥98% |
|
|
源叶 | S40475-10mg | 10mg | 期货,请咨询 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... AST-1306 TsOH |
≥98% |
|
|
源叶 | S40475-50mg | 50mg | 期货,请咨询 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... AST-1306 TsOH |
≥98% |
|
|
源叶 | S59274-1ml | 1ml | 期货,请咨询 |
N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]... Allitinib (AST-1306) |
10mM in DMSO |
|
|
Target Mol | T6331-1mg | 1mg | 现货 |
艾力替尼 Allitinib tosylate |
98.52% |
|
|
Target Mol | T6331-5mg | 5mg | 现货 |
艾力替尼 Allitinib tosylate |
98.52% |
|
|
Target Mol | T6331-10mg | 10mg | 现货 |
艾力替尼 Allitinib tosylate |
98.52% |
|
|
Target Mol | T6331-25mg | 25mg | 现货 |
艾力替尼 Allitinib tosylate |
98.52% |
|
|
Target Mol | T6331-50mg | 50mg | 现货 |
艾力替尼 Allitinib tosylate |
98.52% |
|
|
Target Mol | T6331-100mg | 100mg | 现货 |
艾力替尼 Allitinib tosylate |
98.52% |
|
|
Target Mol | T6331-200mg | 200mg | 现货 |
艾力替尼 Allitinib tosylate |
98.52% |
|
|
Target Mol | T6331-1mL | 1mL | 现货 |
艾力替尼 Allitinib tosylate |
98.52% |
|
|
Am | A954947-25mg | 25mg | 现货 |
Allitinib tosylate Allitinib tosylate |
99% |
|
|
Am | A954947-5mg | 5mg | 现货 |
Allitinib tosylate Allitinib tosylate |
99% |
|
|
Am | A954947-10mg | 10mg | 现货 |
Allitinib tosylate Allitinib tosylate |
99% |
|
|
Am | A954947-1mg | 1mg | 现货 |
Allitinib tosylate Allitinib tosylate |
99% |
|
|
Am | A954947-50mg | 50mg | 现货 |
Allitinib tosylate Allitinib tosylate |
99% |
|
|
MCE | HY-13427-50mg | 50mg | 现货 |
Allitinib tosylate Allitinib tosylate |
99.83% |
|
|
MCE | HY-13427-25mg | 25mg | 现货 |
Allitinib tosylate Allitinib tosylate |
99.83% |
|
|
MCE | HY-13427-10mg | 10mg | 现货 |
Allitinib tosylate Allitinib tosylate |
99.83% |
|
|
MCE | HY-13427-10mM*1mL | 10mM*1mL | 现货 |
Allitinib tosylate Allitinib tosylate |
99.83% |
|
|
MCE | HY-13427-5mg | 5mg | 现货 |
Allitinib tosylate Allitinib tosylate |
99.83% |
|
|
MCE | HY-13427-1mg | 1mg | 现货 |
Allitinib tosylate Allitinib tosylate |
99.83% |
|
|